Date published: 2025-11-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1J4 Activators

Phosphodiesterase inhibitors such as IBMX, caffeine, and theophylline contribute to the sustained activation of GPCRs by preventing the degradation of cAMP. This action ensures a prolonged intracellular signaling cascade which is crucial for GPCR-mediated responses. Theophylline and caffeine, being non-selective phosphodiesterase inhibitors, ensure that cAMP persists in the cell, indirectly amplifying the signaling through OR1J4. Prostaglandin E2 engages its own receptors but also modulates cAMP levels, thereby altering the cellular signaling environment and indirectly influencing OR1J4. Histamine, by binding to its receptors, can affect cAMP dynamics, thereby influencing the signaling processes that OR1J4 receptors are part of.

Nicotine, through its interaction with nicotinic acetylcholine receptors, has the capacity to indirectly modify the signaling within the network of GPCRs, which could extend to OR1J4. Capsaicin and menthol, known for their ability to activate TRP channels, alter intracellular calcium levels, and by doing so, they can modulate GPCR-mediated pathways, which includes the potential to influence OR1J4. L-Arginine, a precursor for nitric oxide synthesis, can indirectly influence GPCR signaling through cGMP pathways, which may interact with OR1J4-related pathways. Sodium butyrate affects gene expression and has the potential to alter the expression and functionality of GPCRs such as OR1J4. GTPγS, a non-hydrolyzable analog of GTP, keeps G proteins in an active state, thus potentiating the signaling pathways of GPCRs, which could affect the activity of OR1J4.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Directly stimulates adenylyl cyclase, which can increase intracellular cAMP levels and activate GPCR signaling, impacting OR1J4.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Inhibits phosphodiesterases, raising cAMP levels and possibly enhancing GPCR-mediated signaling, indirectly affecting OR1J4.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
5 g
100 g
250 g
1 kg
5 kg
$32.00
$66.00
$95.00
$188.00
$760.00
13
(1)

Acts as a non-selective phosphodiesterase inhibitor, maintaining elevated cAMP levels, which can enhance GPCR-mediated signaling pathways including those related to OR1J4.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$31.00
$83.00
6
(0)

Another non-selective phosphodiesterase inhibitor, increases cAMP and can potentiate GPCR signaling, which may include OR1J4.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$56.00
$156.00
$270.00
$665.00
37
(1)

Engages its own GPCRs, potentially altering cAMP levels and thereby influencing the signaling landscape of OR1J4.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$92.00
$277.00
$969.00
7
(1)

Activates histamine receptors that can modify cAMP dynamics, possibly affecting OR1J4 activity through these changes.

Capsaicin

404-86-4sc-3577
sc-3577C
sc-3577D
sc-3577A
50 mg
250 mg
500 mg
1 g
$94.00
$173.00
$255.00
$423.00
26
(1)

Stimulates TRPV1 channels that can affect calcium influx, influencing GPCR function, which may include OR1J4.

(−)-Menthol

2216-51-5sc-202705
sc-202705A
1 g
50 g
$20.00
$40.00
2
(1)

Activates TRP channels and alters calcium levels, which can modulate GPCR-mediated pathways that could affect OR1J4.

L-Arginine

74-79-3sc-391657B
sc-391657
sc-391657A
sc-391657C
sc-391657D
5 g
25 g
100 g
500 g
1 kg
$20.00
$30.00
$60.00
$215.00
$345.00
2
(0)

A nitric oxide precursor, can modulate GPCR activity through cGMP pathways, potentially affecting OR1J4 signaling.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Histone deacetylase inhibitor that can change gene expression and impact GPCR expression/function, potentially affecting OR1J4.